IRIS Accounts Production v26.1.0.640 06715726 Board of Directors 1.1.25 31.12.25 31.12.25 false true false false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh067157262024-12-31067157262025-12-31067157262025-01-012025-12-31067157262023-12-31067157262024-01-012024-12-31067157262024-12-3106715726ns15:EnglandWales2025-01-012025-12-3106715726ns14:PoundSterling2025-01-012025-12-3106715726ns10:Director12025-01-012025-12-3106715726ns10:PrivateLimitedCompanyLtd2025-01-012025-12-3106715726ns10:SmallEntities2025-01-012025-12-3106715726ns10:AuditExempt-NoAccountantsReport2025-01-012025-12-3106715726ns10:SmallCompaniesRegimeForDirectorsReport2025-01-012025-12-3106715726ns10:SmallCompaniesRegimeForAccounts2025-01-012025-12-3106715726ns10:FullAccounts2025-01-012025-12-310671572612025-01-012025-12-3106715726ns10:OrdinaryShareClass12025-01-012025-12-3106715726ns10:Director22025-01-012025-12-3106715726ns10:Director32025-01-012025-12-3106715726ns10:CompanySecretary12025-01-012025-12-3106715726ns10:RegisteredOffice2025-01-012025-12-3106715726ns5:CurrentFinancialInstruments2025-12-3106715726ns5:CurrentFinancialInstruments2024-12-3106715726ns5:Non-currentFinancialInstruments2025-12-3106715726ns5:Non-currentFinancialInstruments2024-12-3106715726ns5:ShareCapital2025-12-3106715726ns5:ShareCapital2024-12-3106715726ns5:SharePremium2025-12-3106715726ns5:SharePremium2024-12-3106715726ns5:RetainedEarningsAccumulatedLosses2025-12-3106715726ns5:RetainedEarningsAccumulatedLosses2024-12-3106715726ns5:IntangibleAssetsOtherThanGoodwill2025-01-012025-12-3106715726ns5:PlantMachinery2025-01-012025-12-3106715726ns5:IntangibleAssetsOtherThanGoodwill2024-12-3106715726ns5:IntangibleAssetsOtherThanGoodwill2025-12-3106715726ns5:IntangibleAssetsOtherThanGoodwill2024-12-3106715726ns5:PlantMachinery2024-12-3106715726ns5:PlantMachinery2025-12-3106715726ns5:PlantMachinery2024-12-3106715726ns5:WithinOneYearns5:CurrentFinancialInstruments2025-12-3106715726ns5:WithinOneYearns5:CurrentFinancialInstruments2024-12-3106715726ns10:OrdinaryShareClass12025-12-31
REGISTERED NUMBER: 06715726 (England and Wales)















Financial Statements for the Year Ended 31st December 2025

for

M. D. Diagnostics Limited

M. D. Diagnostics Limited (Registered number: 06715726)

Contents of the Financial Statements
for the Year Ended 31st December 2025










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


M. D. Diagnostics Limited

Company Information
for the Year Ended 31st December 2025







DIRECTORS: D Quirke
N J Diss
S L Mackin





SECRETARY: D Quirke





REGISTERED OFFICE: 1-3 Manor Road
Chatham
Kent
ME4 6AE





REGISTERED NUMBER: 06715726 (England and Wales)





ACCOUNTANTS: Beak Kemmenoe
Chartered Accountants
1-3 Manor Road
Chatham
Kent
ME4 6AE

M. D. Diagnostics Limited (Registered number: 06715726)

Balance Sheet
31st December 2025

2025 2024
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 20,372 18,502
Tangible assets 5 32,242 12,730
52,614 31,232

CURRENT ASSETS
Stocks 112,614 138,898
Debtors 6 302,805 268,011
Cash at bank 127,354 126,393
542,773 533,302
CREDITORS
Amounts falling due within one year 7 154,751 125,923
NET CURRENT ASSETS 388,022 407,379
TOTAL ASSETS LESS CURRENT
LIABILITIES

440,636

438,611

CREDITORS
Amounts falling due after more than one
year

8

-

9,158
NET ASSETS 440,636 429,453

CAPITAL AND RESERVES
Called up share capital 9 125 125
Share premium 249,975 249,975
Retained earnings 190,536 179,353
SHAREHOLDERS' FUNDS 440,636 429,453

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2025.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2025 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

M. D. Diagnostics Limited (Registered number: 06715726)

Balance Sheet - continued
31st December 2025


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 13th May 2026 and were signed on its behalf by:





D Quirke - Director


M. D. Diagnostics Limited (Registered number: 06715726)

Notes to the Financial Statements
for the Year Ended 31st December 2025


1. STATUTORY INFORMATION

M. D. Diagnostics Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
The turnover is the amount derived from ordinary activities, and stated after trade discounts, other sales taxes and net of VAT.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Patents are being amortised evenly over their estimated useful life of 20 years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development
Expenditure on research and development is written off in the year in which it is incurred.


M. D. Diagnostics Limited (Registered number: 06715726)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2025


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 5 (2024 - 6 ) .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1st January 2025 20,910
Additions 3,012
At 31st December 2025 23,922
AMORTISATION
At 1st January 2025 2,408
Charge for year 1,142
At 31st December 2025 3,550
NET BOOK VALUE
At 31st December 2025 20,372
At 31st December 2024 18,502

5. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st January 2025 57,131
Additions 23,743
At 31st December 2025 80,874
DEPRECIATION
At 1st January 2025 44,401
Charge for year 4,231
At 31st December 2025 48,632
NET BOOK VALUE
At 31st December 2025 32,242
At 31st December 2024 12,730

M. D. Diagnostics Limited (Registered number: 06715726)

Notes to the Financial Statements - continued
for the Year Ended 31st December 2025


6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Trade debtors 104,338 62,700
Other debtors and prepayments 198,467 205,311
302,805 268,011

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2025 2024
£    £   
Bank loans and overdrafts 8,737 10,000
Trade creditors 70,950 43,541
Taxation and social security 8,001 7,323
Other creditors and accruals 67,063 65,059
154,751 125,923

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
2025 2024
£    £   
Bank loans - 9,158

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2025 2024
value: £    £   
125 Ordinary £1 125 125

10. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is D Quirke by virtue of his majority shareholding.